硬化症-话题@MedSci

#硬化症#

413篇内容 | 2634人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1982943, encodeId=f9d0198294318, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=NEJM：复发性多发性硬化症治疗奥瑞珠单抗与干扰素β-1a，哪家强？, objectType=article, longId=85090, objectId=262c8509025, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=262c8509025, replyNumber=0, likeNumber=73, createdTime=2017-04-22, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=262c8509025, moduleTitle=NEJM：复发性多发性硬化症治疗奥瑞珠单抗与干扰素β-1a，哪家强？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=262c8509025)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982933, encodeId=ebc51982933ff, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=ECTRIMS 2016：百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta疗效显著优于Avonex（干扰素β-1a）, objectType=article, longId=78356, objectId=ead2e8356ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ead2e8356ce, replyNumber=0, likeNumber=58, createdTime=2017-02-25, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ead2e8356ce, moduleTitle=ECTRIMS 2016：百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta疗效显著优于Avonex（干扰素β-1a）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ead2e8356ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982941, encodeId=ab701982941b9, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=【盘点】近期多发性硬化症（MS）相关研究进展, objectType=article, longId=81594, objectId=e92f81594a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92f81594a0, replyNumber=0, likeNumber=115, createdTime=2017-04-27, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92f81594a0, moduleTitle=【盘点】近期多发性硬化症（MS）相关研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e92f81594a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982931, encodeId=a2d7198293197, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=CTRIMS 2016：罗氏新药Ocrevus（一年注射2次）显著提高多发性硬化症疾病控制, objectType=article, longId=77935, objectId=4c8de7935c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4c8de7935c5, replyNumber=0, likeNumber=58, createdTime=2017-07-11, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4c8de7935c5, moduleTitle=CTRIMS 2016：罗氏新药Ocrevus（一年注射2次）显著提高多发性硬化症疾病控制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4c8de7935c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982934, encodeId=997e198293485, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=ESTRIMS 2016：赛诺菲Lemtrada治疗复发缓解型多发性硬化症（RRMS）疗效持续长达6年, objectType=article, longId=78357, objectId=6d5ae8357af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d5ae8357af, replyNumber=0, likeNumber=48, createdTime=2017-07-14, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d5ae8357af, moduleTitle=ESTRIMS 2016：赛诺菲Lemtrada治疗复发缓解型多发性硬化症（RRMS）疗效持续长达6年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d5ae8357af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982920, encodeId=e224198292008, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neuron：重磅！基因突变或可解释多发性硬化症发病之谜, objectType=article, longId=69984, objectId=11916998487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=11916998487, replyNumber=0, likeNumber=84, createdTime=2016-11-26, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=11916998487, moduleTitle=Neuron：重磅！基因突变或可解释多发性硬化症发病之谜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=11916998487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982936, encodeId=bc3d198293666, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：症状性病变在多发性硬化症诊断和预后中的作用, objectType=article, longId=79246, objectId=2d0ce92460b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d0ce92460b, replyNumber=0, likeNumber=94, createdTime=2017-01-18, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d0ce92460b, moduleTitle=Neurology：症状性病变在多发性硬化症诊断和预后中的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d0ce92460b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982935, encodeId=54bd19829351d, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=【盘点】9月多发性硬化症研究进展一览, objectType=article, longId=78807, objectId=05a3e880763, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05a3e880763, replyNumber=0, likeNumber=67, createdTime=2017-08-23, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05a3e880763, moduleTitle=【盘点】9月多发性硬化症研究进展一览, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05a3e880763)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982927, encodeId=a85e198292ee8, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=J Rheumatol：多发性肌炎让系统性硬化症患者生存更糟糕, objectType=article, longId=75475, objectId=d52ae5475ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d52ae5475ee, replyNumber=0, likeNumber=61, createdTime=2017-03-14, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d52ae5475ee, moduleTitle=J Rheumatol：多发性肌炎让系统性硬化症患者生存更糟糕, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d52ae5475ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982947, encodeId=53a6198294e58, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=JAMA Neurol：研究者发现肌萎缩侧索硬化症(ALS)的治疗应答生物标记物, objectType=article, longId=95039, objectId=216a95039a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=216a95039a9, replyNumber=0, likeNumber=87, createdTime=2017-04-07, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=216a95039a9, moduleTitle=JAMA Neurol：研究者发现肌萎缩侧索硬化症(ALS)的治疗应答生物标记物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=216a95039a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982945, encodeId=6db5198294561, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Sci Rep：突破性成果！研究人员发现指示多发性硬化症的血液生物标志物, objectType=article, longId=88398, objectId=509b8839867, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=509b8839867, replyNumber=0, likeNumber=80, createdTime=2017-10-13, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=509b8839867, moduleTitle=Sci Rep：突破性成果！研究人员发现指示多发性硬化症的血液生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=509b8839867)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982937, encodeId=22e4198293ea2, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：多发性硬化症女性能连续妊娠吗?, objectType=article, longId=79247, objectId=6ea0e924751, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea0e924751, replyNumber=0, likeNumber=98, createdTime=2017-01-08, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea0e924751, moduleTitle=Neurology：多发性硬化症女性能连续妊娠吗?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea0e924751)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982944, encodeId=a4721982944c8, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Heart：心肺运动试验可用于检测系统性硬化症患者的肺动脉高压, objectType=article, longId=86994, objectId=7e038699453, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e038699453, replyNumber=0, likeNumber=81, createdTime=2017-12-21, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e038699453, moduleTitle=Heart：心肺运动试验可用于检测系统性硬化症患者的肺动脉高压, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e038699453)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982940, encodeId=8e6819829400f, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Neurology：女性增加体力活动可降低多发性硬化症危险, objectType=article, longId=81034, objectId=25ad81034c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25ad81034c0, replyNumber=0, likeNumber=72, createdTime=2017-02-14, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25ad81034c0, moduleTitle=Neurology：女性增加体力活动可降低多发性硬化症危险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25ad81034c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982915, encodeId=88ef1982915ca, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=Lancet：托珠单抗治疗系统性硬化症患者的疗效和安全性, objectType=article, longId=67639, objectId=1d7e6e63988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d7e6e63988, replyNumber=0, likeNumber=73, createdTime=2016-11-04, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d7e6e63988, moduleTitle=Lancet：托珠单抗治疗系统性硬化症患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d7e6e63988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982916, encodeId=b0261982916f7, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=JAMA：马西替坦治疗系统性硬化症患者的指端溃疡效果不佳, objectType=article, longId=67968, objectId=48086e9683f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48086e9683f, replyNumber=0, likeNumber=79, createdTime=2017-04-06, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48086e9683f, moduleTitle=JAMA：马西替坦治疗系统性硬化症患者的指端溃疡效果不佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=48086e9683f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982914, encodeId=0176198291450, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=FDA授予Epidiolex（大麻二酚）治疗结节性硬化症（TSC）的孤儿药地位, objectType=article, longId=67289, objectId=0b2e6e289c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b2e6e289c8, replyNumber=0, likeNumber=0, createdTime=2016-11-06, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b2e6e289c8, moduleTitle=FDA授予Epidiolex（大麻二酚）治疗结节性硬化症（TSC）的孤儿药地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b2e6e289c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982939, encodeId=566119829394e, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=源于冬虫夏草的药物芬戈莫德如何有效治疗多发性硬化症？, objectType=article, longId=80946, objectId=ce4d8094654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce4d8094654, replyNumber=0, likeNumber=57, createdTime=2017-03-13, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce4d8094654, moduleTitle=源于冬虫夏草的药物芬戈莫德如何有效治疗多发性硬化症？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce4d8094654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982919, encodeId=5b8c198291979, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=科学家首次发现多发性硬化症致病基因突变, objectType=article, longId=69875, objectId=9d71698e565, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d71698e565, replyNumber=0, likeNumber=64, createdTime=2016-09-26, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d71698e565, moduleTitle=科学家首次发现多发性硬化症致病基因突变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d71698e565)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1982930, encodeId=eeb61982930e1, content=<a href='/topic/show?id=a7a7e359478' target=_blank style='color:#2F92EE;'>#硬化症#</a>, objectTitle=CTRIMS 2016：诺华新药BAF312治疗继发进展型多发性硬化症（SPMS）关键III期显著降低残疾进展风险, objectType=article, longId=77933, objectId=e078e79331a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e078e79331a, replyNumber=0, likeNumber=68, createdTime=2017-09-01, rootId=0, userName=30397604, userId=a691420, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e078e79331a, moduleTitle=CTRIMS 2016：诺华新药BAF312治疗继发进展型多发性硬化症（SPMS）关键III期显著降低残疾进展风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e078e79331a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

硬化症

2020-05-29

30397604 (审核中...)

前往app查看评论内容

#硬化症#

NEJM：复发性多发性硬化症治疗奥瑞珠单抗与干扰素β-1a，哪家强？

2017-04-22

30397604 (审核中...)

前往app查看评论内容

#硬化症#

ECTRIMS 2016：百健/艾伯维每月一次皮下注射多发性硬化症药物Zinbryta疗效显著优于Avonex（干扰素β-1a）

2017-02-25

30397604 (审核中...)

前往app查看评论内容

#硬化症#

【盘点】近期多发性硬化症（MS）相关研究进展

2017-04-27

30397604 (审核中...)

前往app查看评论内容

#硬化症#

CTRIMS 2016：罗氏新药Ocrevus（一年注射2次）显著提高多发性硬化症疾病控制

2017-07-11

30397604 (审核中...)

前往app查看评论内容

#硬化症#

ESTRIMS 2016：赛诺菲Lemtrada治疗复发缓解型多发性硬化症（RRMS）疗效持续长达6年

2017-07-14

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neuron：重磅！基因突变或可解释多发性硬化症发病之谜

2016-11-26

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：症状性病变在多发性硬化症诊断和预后中的作用

2017-01-18

30397604 (审核中...)

前往app查看评论内容

#硬化症#

【盘点】9月多发性硬化症研究进展一览

2017-08-23

30397604 (审核中...)

前往app查看评论内容

#硬化症#

J Rheumatol：多发性肌炎让系统性硬化症患者生存更糟糕

2017-03-14

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JAMA Neurol：研究者发现肌萎缩侧索硬化症(ALS)的治疗应答生物标记物

2017-04-07

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Sci Rep：突破性成果！研究人员发现指示多发性硬化症的血液生物标志物

2017-10-13

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：多发性硬化症女性能连续妊娠吗?

2017-01-08

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Heart：心肺运动试验可用于检测系统性硬化症患者的肺动脉高压

2017-12-21

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Neurology：女性增加体力活动可降低多发性硬化症危险

2017-02-14

30397604 (审核中...)

前往app查看评论内容

#硬化症#

Lancet：托珠单抗治疗系统性硬化症患者的疗效和安全性

2016-11-04

30397604 (审核中...)

前往app查看评论内容

#硬化症#

JAMA：马西替坦治疗系统性硬化症患者的指端溃疡效果不佳

2017-04-06

30397604 (审核中...)

前往app查看评论内容

#硬化症#

FDA授予Epidiolex（大麻二酚）治疗结节性硬化症（TSC）的孤儿药地位

2016-11-06

30397604 (审核中...)

前往app查看评论内容

#硬化症#

源于冬虫夏草的药物芬戈莫德如何有效治疗多发性硬化症？

2017-03-13

30397604 (审核中...)

前往app查看评论内容

#硬化症#

科学家首次发现多发性硬化症致病基因突变

2016-09-26

30397604 (审核中...)

前往app查看评论内容

#硬化症#

CTRIMS 2016：诺华新药BAF312治疗继发进展型多发性硬化症（SPMS）关键III期显著降低残疾进展风险

2017-09-01

科室
- - 订阅+
  - 更多科室
工具
服务